No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 Cases-Reference-Cited by-同舟云学术

No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 Cases

Published:2014-03-20 Issue:3 Volume:9 Page:e92585
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xu Bei,Liu Peng

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Angioimmunoblastic T-cell lymphoma;E Iannitto;Crit Rev Oncol Hematol,2008

2. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma;L de Leval;Br J Haematol,2010

3. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project;T Rüdiger;Ann Oncol,2002

4. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial;A Gallamini;Blood,2007

5. A phase II study of bortezomib in combination with intensified CHOP-like regimen (ACVBP) in patients with previously untreated T-cell lymphoma: results of the GELA LNH05–1T trial;A Delmer;Journal of Clinical Oncolology (ASCO Meeting Abstracts),2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent Rash and Anemia: A Diagnostic Challenge of Angioimmunoblastic T-cell Lymphoma Mimicking Parvovirus B19 Infection;Cureus;2024-09-03

2. Single‐cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T‐cell lymphoma;Cancer Science;2024-06-06

3. Risk prediction and treatment assessment in glioma patients using SEER database: a prospective observational study;BMJ Open;2023-12

4. A Case of Angioimmunoblastic T-Cell Lymphoma and the Difficulties of Diagnosis;Cureus;2023-09-02

5. Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles;Frontiers in Oncology;2023-08-10